| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 421,4 k € | -47.8% | 807,0 k € | — | — | — | — | — | — | — | — | — | ||||||||||
| Gross margin | — | — | 417,8 k € | -82.9% | 2,4 M € | +3.3% | 2,4 M € | +65.4% | 1,4 M € | +108.9% | 682,7 k € | -44.3% | 1,2 M € | +38.6% | 885,0 k € | +33.4% | 663,5 k € | +107.6% | 319,6 k € | |||
| EBITDA | -603,9 k € | -4.6% | -577,5 k € | -82.7% | -316,1 k € | -115.9% | 2,0 M € | +8.2% | 1,8 M € | +103.7% | 900,1 k € | +4568.5% | 19,3 k € | -97.8% | 874,3 k € | +25.7% | 695,4 k € | +22.6% | 567,2 k € | +120.0% | 257,7 k € | |
| Operating profit | -603,9 k € | -4.3% | -579,1 k € | -69.4% | -342,0 k € | -117.5% | 2,0 M € | +9.2% | 1,8 M € | +114.8% | 832,7 k € | +1651.7% | -53,7 k € | -106.4% | 833,0 k € | +22.0% | 682,8 k € | +22.9% | 555,5 k € | +122.7% | 249,4 k € | |
| Profit/loss | 389,1 k € | -83.9% | 2,4 M € | +788.0% | -351,4 k € | -123.8% | 1,5 M € | +10.2% | 1,3 M € | +141.5% | 553,8 k € | +2142.5% | 24,7 k € | -95.7% | 577,5 k € | +44.6% | 399,5 k € | +4.6% | 381,7 k € | +134.1% | 163,1 k € | |
| Equity | 5,3 M € | +7.9% | 4,9 M € | +97.5% | 2,5 M € | -12.4% | 2,8 M € | +108.7% | 1,4 M € | +7051.8% | 19,0 k € | -98.8% | 1,6 M € | +2.0% | 1,5 M € | +60.8% | 950,5 k € | +72.5% | 551,0 k € | +225.5% | 169,3 k € | |
| Total assets | 41,5 M € | +1.1% | 41,1 M € | -2.0% | 42,0 M € | +142.9% | 17,3 M € | +573.6% | 2,6 M € | +276.4% | 681,3 k € | -69.0% | 2,2 M € | -28.4% | 3,1 M € | +98.4% | 1,5 M € | +56.4% | 988,5 k € | +183.0% | 349,3 k € | |
| Cash | 353,3 k € | -4.4% | 369,7 k € | -3.1% | 381,4 k € | -85.5% | 2,6 M € | +128.1% | 1,2 M € | +274.7% | 308,3 k € | -56.5% | 708,6 k € | -42.4% | 1,2 M € | +68.5% | 729,6 k € | +53.6% | 474,9 k € | +64.9% | 288,1 k € | |
| Debts | 36,3 M € | +0.2% | 36,2 M € | -8.1% | 39,4 M € | +174.0% | 14,4 M € | +1155.1% | 1,1 M € | +102.9% | 565,0 k € | -5.7% | 599,1 k € | -26.5% | 814,6 k € | +36.8% | 595,6 k € | +36.2% | 437,4 k € | +143.2% | 179,8 k € | |
| Staff | 5,1 | 6,5 | 6,9 | 5,1 | 6,3 | 7,8 | 6,9 | 4,7 | — | — | 0,9 | |||||||||||
Private limited company · Herzele · incorporated on 19/05/2014 · 5,1 ETP
Private limited company profitable and well capitalised.
Solid counterparty for a standard engagement.
NAMSA BELGIUM is a Private limited company incorporated in 2014. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Herzele. It employs on average 5,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette